Financials in USD. Standardized financial statements.
A compact view of how Neuropathix, Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|
| Revenue? | $183,477 | $0 | $126,027 | $173,889 | $1,154 | $34,970 | $145,000 |
| Revenue Growth? | 0.0% | -100.0% | -27.5% | +14968.4% | -96.7% | -75.9% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $21,000 | $51,000 |
| Gross Profit? | $183,477 | $0 | $126,027 | $173,889 | $1,154 | $13,970 | $94,000 |
| Gross Margin? | +100.0% | 0.0% | +100.0% | +100.0% | +100.0% | +39.9% | +64.8% |
| Operating Expenses? | $2.94M | $4.47M | $2.46M | $1.24M | $23,597 | $45,994 | $89,258 |
| Operating Income? | -$2.94M | -$4.47M | -$2.33M | -$1.06M | -$22,443 | -$32,024 | $4,742 |
| EBITDA? | -$2.92M | -$4.35M | -$1.35M | $40,734 | -$22,443 | -$32,024 | $4,742 |
| Income Before Tax | -$3.56M | -$4.54M | -$3.45M | $1.74M | -$22,443 | -$32,024 | $4,742 |
| Income Tax Expense | $434,589 | $1.03M | $1.11M | $811,984 | $0 | $0 | $0 |
| Net Income? | -$3.99M | -$5.57M | -$4.57M | $936,815 | -$22,443 | -$32,024 | $4,742 |
| EPS? | $-0.05 | $-0.07 | $-0.06 | $0.01 | $-0.00 | $-0.00 | $0.00 |
| Diluted EPS? | $-0.05 | $-0.07 | $-0.06 | $0.01 | $-0.00 | $-0.00 | $0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality